GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heartseed Inc (TSE:219A) » Definitions » Total Long-Term Liabilities

Heartseed (TSE:219A) Total Long-Term Liabilities : 円161 Mil (As of Apr. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Heartseed Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Heartseed's Total Long-Term Liabilities for the quarter that ended in Apr. 2025 was 円161 Mil.


Heartseed Total Long-Term Liabilities Historical Data

The historical data trend for Heartseed's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartseed Total Long-Term Liabilities Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24
Total Long-Term Liabilities
66.06 206.13 162.27

Heartseed Semi-Annual Data
Oct22 Oct23 Apr24 Oct24 Apr25
Total Long-Term Liabilities 66.06 206.13 180.86 162.27 160.85

Heartseed Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Heartseed Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Heartseed's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartseed Business Description

Industry
Traded in Other Exchanges
N/A
Address
1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is engaged in developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.

Heartseed Headlines

No Headlines